FASLG and neoplasm: In conclusion, we demonstrated that in human MFH cells DcR3 may increase tumor progression as a decoy, promoting cell proliferation via inhibition of FasL-induced apoptosis and as a non-decoy, regulating cell migration and invasion by MMP-2 activation via the PI3K/Akt pathway (Fig. 7).